News
Fermelanta Raises $13.8M Series A to Scale Microbial Production of Plant Metabolites
Japan-based Fermelanta secured JPY2 billion ($13.8 million) to advance R&D, enhance lab-to-pilot scale-up, and expand partnerships with CDMOs for microbial synthesis of plant-derived compounds, including morphine.
Shattuck Labs raises up to $103M to fund therapeutic antibody development
The funding will support Phase 1 and multiple Phase 2 trials of SL-325, an antibody designed to block the DR3/TL1A pathway with the potential to improve treatment for Crohn’s disease, ulcerative colitis, and other inflammatory conditions.
iNtRON Bio Files Patents for IMPA™ Gene Editing Platform Targeting Pasteurella Bacteriophages
iNtRON Bio has filed two patents for its IMPA™ platform, which combines CRISPR-Cas9 and recombination-based methods to engineer Pasteurella bacteriophages. The technology enables modular phages with diverse payloads for applications in gene editing, protein labeling, and capsid engineering.
SOHM Advances ABBIE Gene Editing Platform with Breakthrough in Human Cell Modification
SOHM announced that its ABBIE version 2 platform, equipped with an enhanced dCas12a domain, has successfully modified cultured human cells, marking a key step toward commercial-ready gene editing technology and strengthening the company’s strategic partnership and licensing prospects
Noblis Sends DNA Data Storage and Synthetic Biology Experiments to the ISS
The mission includes Helix Horizons, a DNA-based data storage system to test ultra-stable archives in space, and ScIPS, a synthetic microbial consortia platform designed to enable sustainable nutrition and adaptive biomanufacturing for deep space missions
Levelle Nutrition Launches Cycle Syncing Protein with Helaina’s Fermented Lactoferrin
The U.S.-based company introduced a protein powder formulated with Helaina’s effera™, a precision-fermented, human-identical lactoferrin, to support women’s nutritional needs across the menstrual cycle.
Corbion and BRAIN Biotech Partner on Biobased Antimicrobial Development
A collaboration to develop novel biobased antimicrobial compounds and derivatives, combining BRAIN’s expertise in enzyme and microbial strain technologies with Corbion’s preservation knowledge and scale-up capabilities to advance natural food preservation solutions
Atlantic Fish Co. Secures $305K NSF SBIR Grant to Advance Cultivated Seafood
The Raleigh-based startup will use the funding to scale production of cultivated white fish, aiming to provide a sustainable alternative amid rising seafood demand and pressures from global overfishing.
Industry leaders use Knowledge Hub to explore 763+ Synthetic Biology news
Gain unparalleled insights, and drive your innovation forward.
Let’s shape tomorrow, today!